Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond C Love
Deanna L Kelly

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
The Mental Health Clinician|March 8, 2019
Psychiatric pharmacist's role in overcoming barriers to clozapine use and improving managementDeanna L Kelly, Raymond C Love
Psychiatric Services (Washington, D.C.)|October 17, 2017
Addressing Barriers to Clozapine Underutilization: A National EffortDeanna L Kelly, Oliver Freudenreich, MacKenzie A Sayer, et al.
Psychiatric Services (Washington, D.C.)|March 5, 2005
Comparison of clozapine use in Maryland and in Victoria, AustraliaRobert R Conley, Deanna L Kelly, Tim J Lambert, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 4, 2003
Rehospitalization risk with second-generation and depot antipsychoticsRobert R Conley, Deanna L Kelly, Raymond C Love, et al.
Journal of Child and Adolescent Psychopharmacology|May 15, 2004
Atypical antipsychotic use in a state hospital inpatient adolescent populationDeanna L Kelly, Raymond C Love, Marie MacKowick, et al.
Schizophrenia Bulletin|December 16, 2006
Clozapine underutilization and discontinuation in African Americans due to leucopeniaDeanna L Kelly, Julie Kreyenbuhl, Lisa Dixon, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|June 24, 2008
Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapineDeanna L Kelly, Robert R Conley, Raymond C Love, et al.
The Psychiatric Quarterly|January 25, 2008
Comparison of clozapine response for inpatients in the research setting versus routine clinical practiceDouglas L Boggs, Deanna L Kelly, Raymond C Love, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trialsRobert P McMahon, Deanna L Kelly, Julie Kreyenbuhl, et al.
The Psychiatric Quarterly|January 12, 2019
Effects of Cigarette Smoking and Clozapine Treatment on 20-Year All-Cause & Cardiovascular Mortality in SchizophreniaPatrick A Stolz, Heidi J Wehring, Fang Liu, et al.
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
The Mental Health Clinician|March 8, 2019
Psychiatric pharmacist's role in overcoming barriers to clozapine use and improving managementDeanna L Kelly, Raymond C Love
Psychiatric Services (Washington, D.C.)|October 17, 2017
Addressing Barriers to Clozapine Underutilization: A National EffortDeanna L Kelly, Oliver Freudenreich, MacKenzie A Sayer, et al.
Psychiatric Services (Washington, D.C.)|March 5, 2005
Comparison of clozapine use in Maryland and in Victoria, AustraliaRobert R Conley, Deanna L Kelly, Tim J Lambert, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|July 4, 2003
Rehospitalization risk with second-generation and depot antipsychoticsRobert R Conley, Deanna L Kelly, Raymond C Love, et al.
Journal of Child and Adolescent Psychopharmacology|May 15, 2004
Atypical antipsychotic use in a state hospital inpatient adolescent populationDeanna L Kelly, Raymond C Love, Marie MacKowick, et al.
Schizophrenia Bulletin|December 16, 2006
Clozapine underutilization and discontinuation in African Americans due to leucopeniaDeanna L Kelly, Julie Kreyenbuhl, Lisa Dixon, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|June 24, 2008
Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapineDeanna L Kelly, Robert R Conley, Raymond C Love, et al.
The Psychiatric Quarterly|January 25, 2008
Comparison of clozapine response for inpatients in the research setting versus routine clinical practiceDouglas L Boggs, Deanna L Kelly, Raymond C Love, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 3, 2002
Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trialsRobert P McMahon, Deanna L Kelly, Julie Kreyenbuhl, et al.
The Psychiatric Quarterly|January 12, 2019
Effects of Cigarette Smoking and Clozapine Treatment on 20-Year All-Cause & Cardiovascular Mortality in SchizophreniaPatrick A Stolz, Heidi J Wehring, Fang Liu, et al.
Pageof 18